Urogen Pharma (URGN) Experts Views (BUY SELL) [2024] (URGN) share price target ["experts views"] BUY/SELL -NASDAQ stock exchange

Urogen Pharma URGN Experts view BUY SELL, share price targets for short, mid, long term 2024 NASDAQ stock exchange

NASDAQ stock URGN Urogen Pharma experts views & buy sell levels signals are here. Urogen Pharma forecast & share price targets are here or Urogen Pharma share price targets and URGN Urogen Pharma tomorrow's movements predictions are here or Announcements & NEWS by Urogen Pharma

Stock listed under Health Care

Urogen Pharma share price opened at: 11.60
Urogen Pharma share price closed at: 11.91
Urogen Pharma share price made a High of: 12.04
Urogen Pharma share price made a low of: 11.50

Detailed analysis of what to do in Intraday & BTST tips for Urogen Pharma are here
52 week High of Urogen Pharma: 24.13
52 week Low of Urogen Pharma: 8.69
URGN is trading in the lower range of yearly prices.

Went as high as 17.00 in the last three months (quarter)
Went as low as 10.62 in the last three months (quarter)
URGN is trading in the lower range of the quarterly prices.

The session was a bullish session and prices moved within a range of 11.50 and 12.04, with a volume of -22.04% compared to average volume that Urogen Pharma normally has.

The NASDAQ share URGN Urogen Pharma does not have a defined movement as of now. Keep reading experts views on Urogen Pharma below for shortterm to longterm URGN share prices targets and buy sell signals, points & levels.

NASDAQ URGN Experts Views Urogen Pharma Buy Sell Signals

The share prices have been falling shortly. An initial buy or sell signal has not been generated yet. However, if a BUY/SELL signal is mentioned below then you can choose to take a trade with a strict stoploss.

NASDAQ URGN Experts Views Urogen Pharma MACD Convergence Divergence

Urogen Pharma fast MACD line is below the slow signal MACD line, and in dead cross zone, negative zone

Both the lines are converging, coming close to each other with a difference of 0.01
A BUY signal might be generated soon enough. Keep a close watch. Bookmark this page now & recheck tomorrow...

NASDAQ URGN Urogen Pharma experts views on Support & Resistance

These support and resistance levels of URGN are derived based on analysis of an entire years daily closing prices. These are all extremely strong levels to watch in Urogen Pharma

Levels to watch:

Urogen Pharma has strong support or resistance at 12, 15, 17, 20
The current share price is 11.91

Urogen Pharma URGN share price targets

Levels of 11.7, 11.9, 12.49, 13.22, 14.44 are share price targets for Urogen Pharma URGN Click here for weekly and monthly share price targets

Downside intraday target	11.7
Downside intraday target	11.9
Upside short term target	12.49
Upside mid term target	13.22
Upside long term target	14.44

Experts also view these below mentioned levels as important because Urogen Pharma has been reversing its trend at these levels. These levels below are derived by analysing one year charts of Urogen Pharma

Important support & resistance levels of URGN are 9.41, 13.12, 14.44, 15.25, 15.91, 20.86. Experts view is that the stock of Urogen Pharma might change its trend at one of these levels.

Whether these targets will be achieved or not will depend on the trend of Urogen Pharma. See the Convergence & Divergence section above to understand the trend of NASDAQ share Urogen Pharma. You can also check Future Forecast & Targets for Urogen Pharma or Urogen Pharma share price targets or Tomorrow's predictions for Urogen Pharma

NASDAQ share URGN experts views on candles stick analysis of Urogen Pharma

Daily candle stick experts view of NASDAQ share Urogen Pharma

Latest Urogen Pharma candle stick is a bullish candle, with a length of 2.67%
High made is about 1.09% above the closing.
Urogen Pharma share price high is about -59% of the candle stick body.
Urogen Pharma share price Low made is about 0.87% below the opening.
Low share price is about -67% of the candle stick body.

Experts view is that the stock showed immediate buying from lower levels in this session.

Previous candle stick is a bullish candle, with a length of 0.17%

Two candles back candle stick is a bullish candle, with a length of 2.88%

Weekly candle stick experts view of NASDAQ share Urogen Pharma

Latest Urogen Pharma candle stick is a bullish candle, with a length of 6.24%
High made is about 1.09% above the closing.
Urogen Pharma share price high is about -83% of the candle stick body.
Urogen Pharma share price Low made is about 5.56% below the opening.
Low share price is about -11% of the candle stick body.

Experts view is that the stock showed immediate buying from lower levels in this session.

Previous candle stick is a bearish candle, with a length of 9.74%

two candles back candle stick is a bearish candle, with a length of 0.25%

Monthly candle stick experts view of NASDAQ share Urogen Pharma

Latest Urogen Pharma candle stick is a bearish candle, with a length of 3.53%
High made is about 8.43% above the opening.
Urogen Pharma share price high is about 139% of the candle stick body.
Urogen Pharma share price Low made is about 12.15% below the closing.
Low share price is about 244% of the candle stick body.

It was a long high and stock showed profit booking at the top levels. Experts view is that longer the high, stronger the profit booking or sell off sentiment was.

It was a long low and stock showed buying at the bottom levels. Experts view is that longer the low, stronger the buying sentiment was.

Previous candle stick is a bearish candle, with a length of 3.02%

two candles back candle stick is a bearish candle, with a length of 8.9%

View charts of Urogen Pharma below

Urogen Pharma share price targets or Urogen Pharma Support & Resistance Levels

Daily Charts of URGN , Daily candle stick charts of URGN, Weekly charts of URGN , Monthly Charts of URGN , Moving Averages charts of URGN , MACD charts of URGN , or Technical analysis Reports of URGN , or simply read Tomorrow's predictions of URGN and Future Forecast & share price targets of Urogen Pharma or Urogen Pharma share price targets